Loading…

Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread

The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range...

Full description

Saved in:
Bibliographic Details
Published in:British journal of anaesthesia : BJA 1994-12, Vol.73 (6), p.744-746
Main Authors: SANDERSON, P., READ, J., LITTLEWOOD, D.G., MCKEOWN, D., WILDSMITH, J.A.W.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3
cites
container_end_page 746
container_issue 6
container_start_page 744
container_title British journal of anaesthesia : BJA
container_volume 73
creator SANDERSON, P.
READ, J.
LITTLEWOOD, D.G.
MCKEOWN, D.
WILDSMITH, J.A.W.
description The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range of blocks wider, with the 8% solution. All patients receiving 0.8% glucose had blocks between the T5 and T10 dermatomes, confirming previous work on the benefits of this concentration of glucose. In the two other groups 0.5% bupivacaine containing 0 or 0.8% glucose was injected at the L2–3 interspace. In both groups of patients a wider range of blocks, with a median maximum extent that was higher, was produced. These results demonstrate how glucose concentration may be used to influence the spread of intrathecal solutions and how other factors can obscure the effect of glucose concentration.
doi_str_mv 10.1093/bja/73.6.744
format article
fullrecord <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_bja_73_6_744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0007091217416436</els_id><sourcerecordid>ark_67375_HXZ_CXNQV5RZ_B</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3</originalsourceid><addsrcrecordid>eNptkE1vEzEQhi0EKmnhxhXJBw4gsak_1vbusURAK1UgEKCqF2vWHqcO6W5kO5T-exwlyonTjPQ-M5p5CHnF2ZyzXp4PKzg3cq7npm2fkBlvDW-0MfwpmTHGTMN6Lp6T05xXjHEjenVCTkzXMa30jKyuxoIJXInTSAcsD4i1Qooulkf6drneuikjddPocCwJdtw7CqOnU7nDREMdnVKmcQzrLY4ujsva78A7dLCmPm2XNG8Sgn9BngVYZ3x5qGfk56ePPxaXzfXXz1eLi-vGKdaWhrctdD2owYuOeeGkNLL3AEF2qCV61TIYjOpUMEwIRD44J00QzIiu5TLIM_J-v9elKeeEwW5SvIf0aDmzO2O2GrNGWm2rsYq_3uOb7XCP_ggfFNX8zSGHXD8KCeqX-YhJKYTQrGLNHou54N9jDOm31UYaZS9vbu3i5su3X-r7rf1Qeb3nsar4EzHZ7GIViD4mdMX6Kf7_3n8MxZeY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>SANDERSON, P. ; READ, J. ; LITTLEWOOD, D.G. ; MCKEOWN, D. ; WILDSMITH, J.A.W.</creator><creatorcontrib>SANDERSON, P. ; READ, J. ; LITTLEWOOD, D.G. ; MCKEOWN, D. ; WILDSMITH, J.A.W.</creatorcontrib><description>The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range of blocks wider, with the 8% solution. All patients receiving 0.8% glucose had blocks between the T5 and T10 dermatomes, confirming previous work on the benefits of this concentration of glucose. In the two other groups 0.5% bupivacaine containing 0 or 0.8% glucose was injected at the L2–3 interspace. In both groups of patients a wider range of blocks, with a median maximum extent that was higher, was produced. These results demonstrate how glucose concentration may be used to influence the spread of intrathecal solutions and how other factors can obscure the effect of glucose concentration.</description><identifier>ISSN: 0007-0912</identifier><identifier>EISSN: 1471-6771</identifier><identifier>DOI: 10.1093/bja/73.6.744</identifier><identifier>PMID: 7880656</identifier><identifier>CODEN: BJANAD</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Aged ; Aged, 80 and over ; Anaesthetic techniques ; Anaesthetic techniques, subarachnoid ; Anaesthetics local ; Anaesthetics local, bupivacaine ; Anesthesia, Endotracheal ; Anesthetics. Neuromuscular blocking agents ; baricity ; Biological and medical sciences ; bupivacaine ; Bupivacaine - administration &amp; dosage ; Bupivacaine - chemistry ; Bupivacaine - metabolism ; Bupivacaine - pharmacokinetics ; Dose-Response Relationship, Drug ; Drug Carriers ; Drug Interactions ; Female ; Glucose - administration &amp; dosage ; Glucose - pharmacokinetics ; Humans ; Male ; Medical sciences ; Middle Aged ; Nerve Block ; Neuropharmacology ; Pharmacology. Drug treatments ; Physics ; Physics, baricity ; Spinal Puncture ; subarachnoid ; Time Factors</subject><ispartof>British journal of anaesthesia : BJA, 1994-12, Vol.73 (6), p.744-746</ispartof><rights>1994</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3322260$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7880656$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SANDERSON, P.</creatorcontrib><creatorcontrib>READ, J.</creatorcontrib><creatorcontrib>LITTLEWOOD, D.G.</creatorcontrib><creatorcontrib>MCKEOWN, D.</creatorcontrib><creatorcontrib>WILDSMITH, J.A.W.</creatorcontrib><title>Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread</title><title>British journal of anaesthesia : BJA</title><addtitle>Br J Anaesth</addtitle><description>The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range of blocks wider, with the 8% solution. All patients receiving 0.8% glucose had blocks between the T5 and T10 dermatomes, confirming previous work on the benefits of this concentration of glucose. In the two other groups 0.5% bupivacaine containing 0 or 0.8% glucose was injected at the L2–3 interspace. In both groups of patients a wider range of blocks, with a median maximum extent that was higher, was produced. These results demonstrate how glucose concentration may be used to influence the spread of intrathecal solutions and how other factors can obscure the effect of glucose concentration.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anaesthetic techniques</subject><subject>Anaesthetic techniques, subarachnoid</subject><subject>Anaesthetics local</subject><subject>Anaesthetics local, bupivacaine</subject><subject>Anesthesia, Endotracheal</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>baricity</subject><subject>Biological and medical sciences</subject><subject>bupivacaine</subject><subject>Bupivacaine - administration &amp; dosage</subject><subject>Bupivacaine - chemistry</subject><subject>Bupivacaine - metabolism</subject><subject>Bupivacaine - pharmacokinetics</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Carriers</subject><subject>Drug Interactions</subject><subject>Female</subject><subject>Glucose - administration &amp; dosage</subject><subject>Glucose - pharmacokinetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nerve Block</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Physics</subject><subject>Physics, baricity</subject><subject>Spinal Puncture</subject><subject>subarachnoid</subject><subject>Time Factors</subject><issn>0007-0912</issn><issn>1471-6771</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNptkE1vEzEQhi0EKmnhxhXJBw4gsak_1vbusURAK1UgEKCqF2vWHqcO6W5kO5T-exwlyonTjPQ-M5p5CHnF2ZyzXp4PKzg3cq7npm2fkBlvDW-0MfwpmTHGTMN6Lp6T05xXjHEjenVCTkzXMa30jKyuxoIJXInTSAcsD4i1Qooulkf6drneuikjddPocCwJdtw7CqOnU7nDREMdnVKmcQzrLY4ujsva78A7dLCmPm2XNG8Sgn9BngVYZ3x5qGfk56ePPxaXzfXXz1eLi-vGKdaWhrctdD2owYuOeeGkNLL3AEF2qCV61TIYjOpUMEwIRD44J00QzIiu5TLIM_J-v9elKeeEwW5SvIf0aDmzO2O2GrNGWm2rsYq_3uOb7XCP_ggfFNX8zSGHXD8KCeqX-YhJKYTQrGLNHou54N9jDOm31UYaZS9vbu3i5su3X-r7rf1Qeb3nsar4EzHZ7GIViD4mdMX6Kf7_3n8MxZeY</recordid><startdate>19941201</startdate><enddate>19941201</enddate><creator>SANDERSON, P.</creator><creator>READ, J.</creator><creator>LITTLEWOOD, D.G.</creator><creator>MCKEOWN, D.</creator><creator>WILDSMITH, J.A.W.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19941201</creationdate><title>Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread</title><author>SANDERSON, P. ; READ, J. ; LITTLEWOOD, D.G. ; MCKEOWN, D. ; WILDSMITH, J.A.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anaesthetic techniques</topic><topic>Anaesthetic techniques, subarachnoid</topic><topic>Anaesthetics local</topic><topic>Anaesthetics local, bupivacaine</topic><topic>Anesthesia, Endotracheal</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>baricity</topic><topic>Biological and medical sciences</topic><topic>bupivacaine</topic><topic>Bupivacaine - administration &amp; dosage</topic><topic>Bupivacaine - chemistry</topic><topic>Bupivacaine - metabolism</topic><topic>Bupivacaine - pharmacokinetics</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Carriers</topic><topic>Drug Interactions</topic><topic>Female</topic><topic>Glucose - administration &amp; dosage</topic><topic>Glucose - pharmacokinetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nerve Block</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Physics</topic><topic>Physics, baricity</topic><topic>Spinal Puncture</topic><topic>subarachnoid</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SANDERSON, P.</creatorcontrib><creatorcontrib>READ, J.</creatorcontrib><creatorcontrib>LITTLEWOOD, D.G.</creatorcontrib><creatorcontrib>MCKEOWN, D.</creatorcontrib><creatorcontrib>WILDSMITH, J.A.W.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>British journal of anaesthesia : BJA</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SANDERSON, P.</au><au>READ, J.</au><au>LITTLEWOOD, D.G.</au><au>MCKEOWN, D.</au><au>WILDSMITH, J.A.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread</atitle><jtitle>British journal of anaesthesia : BJA</jtitle><addtitle>Br J Anaesth</addtitle><date>1994-12-01</date><risdate>1994</risdate><volume>73</volume><issue>6</issue><spage>744</spage><epage>746</epage><pages>744-746</pages><issn>0007-0912</issn><eissn>1471-6771</eissn><coden>BJANAD</coden><abstract>The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range of blocks wider, with the 8% solution. All patients receiving 0.8% glucose had blocks between the T5 and T10 dermatomes, confirming previous work on the benefits of this concentration of glucose. In the two other groups 0.5% bupivacaine containing 0 or 0.8% glucose was injected at the L2–3 interspace. In both groups of patients a wider range of blocks, with a median maximum extent that was higher, was produced. These results demonstrate how glucose concentration may be used to influence the spread of intrathecal solutions and how other factors can obscure the effect of glucose concentration.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>7880656</pmid><doi>10.1093/bja/73.6.744</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0912
ispartof British journal of anaesthesia : BJA, 1994-12, Vol.73 (6), p.744-746
issn 0007-0912
1471-6771
language eng
recordid cdi_crossref_primary_10_1093_bja_73_6_744
source Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Aged
Aged, 80 and over
Anaesthetic techniques
Anaesthetic techniques, subarachnoid
Anaesthetics local
Anaesthetics local, bupivacaine
Anesthesia, Endotracheal
Anesthetics. Neuromuscular blocking agents
baricity
Biological and medical sciences
bupivacaine
Bupivacaine - administration & dosage
Bupivacaine - chemistry
Bupivacaine - metabolism
Bupivacaine - pharmacokinetics
Dose-Response Relationship, Drug
Drug Carriers
Drug Interactions
Female
Glucose - administration & dosage
Glucose - pharmacokinetics
Humans
Male
Medical sciences
Middle Aged
Nerve Block
Neuropharmacology
Pharmacology. Drug treatments
Physics
Physics, baricity
Spinal Puncture
subarachnoid
Time Factors
title Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T16%3A59%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20between%20baricity%20(glucose%20concentration)%20and%20other%20factors%20influencing%20intrathecal%20drug%20spread&rft.jtitle=British%20journal%20of%20anaesthesia%20:%20BJA&rft.au=SANDERSON,%20P.&rft.date=1994-12-01&rft.volume=73&rft.issue=6&rft.spage=744&rft.epage=746&rft.pages=744-746&rft.issn=0007-0912&rft.eissn=1471-6771&rft.coden=BJANAD&rft_id=info:doi/10.1093/bja/73.6.744&rft_dat=%3Cistex_cross%3Eark_67375_HXZ_CXNQV5RZ_B%3C/istex_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/7880656&rfr_iscdi=true